↓ Skip to main content

Dove Medical Press

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors

Overview of attention for article published in Biologics: Targets & Therapy, April 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 284)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
54 news outlets
blogs
1 blog
twitter
2 X users
patent
1 patent

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
154 Mendeley
Title
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
Published in
Biologics: Targets & Therapy, April 2014
DOI 10.2147/btt.s37509
Pubmed ID
Authors

Toshio Tanaka, Yoshihiro Hishitani, Atsushi Ogata

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 154 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
Germany 1 <1%
Ireland 1 <1%
United Kingdom 1 <1%
Denmark 1 <1%
Japan 1 <1%
Unknown 147 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 16%
Student > Ph. D. Student 24 16%
Researcher 22 14%
Student > Bachelor 20 13%
Other 11 7%
Other 19 12%
Unknown 33 21%
Readers by discipline Count As %
Medicine and Dentistry 33 21%
Biochemistry, Genetics and Molecular Biology 22 14%
Agricultural and Biological Sciences 20 13%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Immunology and Microbiology 7 5%
Other 25 16%
Unknown 37 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 434. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2021.
All research outputs
#65,246
of 25,374,917 outputs
Outputs from Biologics: Targets & Therapy
#1
of 284 outputs
Outputs of similar age
#446
of 239,197 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 12 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.